Found: 104
Select item for more details and to access through your institution.
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1540, doi. 10.1002/ajh.27023
- By:
- Publication type:
- Article
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1277, doi. 10.1002/ajh.26990
- By:
- Publication type:
- Article
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 413, doi. 10.1002/ajh.26806
- By:
- Publication type:
- Article
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 401, doi. 10.1002/ajh.26466
- By:
- Publication type:
- Article
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 267, doi. 10.1002/ajh.26439
- By:
- Publication type:
- Article
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. 209, doi. 10.1002/ajh.26422
- By:
- Publication type:
- Article
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. 1131, doi. 10.1002/ajh.26269
- By:
- Publication type:
- Article
Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first‐line therapy in multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. 330, doi. 10.1002/ajh.26074
- By:
- Publication type:
- Article
Outcomes of multiple myeloma patients with del 17p undergoing autologous stem cell transplantation.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 1, p. E35, doi. 10.1002/ajh.26023
- By:
- Publication type:
- Article
Refining amyloid complete hematological response: Quantitative serum free light chains superior to ratio.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 11, p. 1280, doi. 10.1002/ajh.25940
- By:
- Publication type:
- Article
Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 637, doi. 10.1002/ajh.25773
- By:
- Publication type:
- Article
Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. 497, doi. 10.1002/ajh.25746
- By:
- Publication type:
- Article
Enhancing the R‐ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 310, doi. 10.1002/ajh.25709
- By:
- Publication type:
- Article
Implications and outcomes of MRD‐negative multiple myeloma patients with immunofixation positivity.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. E60, doi. 10.1002/ajh.25702
- By:
- Publication type:
- Article
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 274, doi. 10.1002/ajh.25697
- By:
- Publication type:
- Article
Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. 4, doi. 10.1002/ajh.25657
- By:
- Publication type:
- Article
Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E8, doi. 10.1002/ajh.25654
- By:
- Publication type:
- Article
Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 10, p. 1066, doi. 10.1002/ajh.25572
- By:
- Publication type:
- Article
Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. 1020, doi. 10.1002/ajh.25566
- By:
- Publication type:
- Article
Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 5, p. E141, doi. 10.1002/ajh.25440
- By:
- Publication type:
- Article
Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. 306, doi. 10.1002/ajh.25365
- By:
- Publication type:
- Article
Utility and prognostic value of <sup>18</sup>F‐FDG positron emission tomography‐computed tomography scans in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. 1518, doi. 10.1002/ajh.25279
- By:
- Publication type:
- Article
Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. 889, doi. 10.1002/ajh.25113
- By:
- Publication type:
- Article
Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. 1146, doi. 10.1002/ajh.24883
- By:
- Publication type:
- Article
The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. E507, doi. 10.1002/ajh.24807
- By:
- Publication type:
- Article
Hematology patient reported symptom screen to assess quality of life for AL amyloidosis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 435, doi. 10.1002/ajh.24676
- By:
- Publication type:
- Article
Trends and outcomes of modern staging of solitary plasmacytoma of bone.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 7, p. 647, doi. 10.1002/ajh.23201
- By:
- Publication type:
- Article
Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 433, doi. 10.1111/ejh.13559
- By:
- Publication type:
- Article
Characterization and prognostic implication of delayed complete response in AL amyloidosis.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 354, doi. 10.1111/ejh.13554
- By:
- Publication type:
- Article
Evaluation of the academic achievements of clinician health services research scientists involved in "pre-K" career development award programs.
- Published in:
- Journal of Clinical & Translational Science, 2021, v. 5, n. 1, p. 1, doi. 10.1017/cts.2021.780
- By:
- Publication type:
- Article
Mayo Clinic's 5-Step Policy for Responding to Bias Incidents.
- Published in:
- AMA Journal of Ethics, 2019, v. 21, n. 6, p. 521, doi. 10.1001/amajethics.2019.521
- By:
- Publication type:
- Article
What accelerates clinician-scientist productivity during the period of a career development award? A qualitative exploration.
- Published in:
- Annals of Family Medicine, 2023, v. 21, p. 1
- By:
- Publication type:
- Article
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. e104, doi. 10.1016/j.clml.2023.11.008
- By:
- Publication type:
- Article
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 456, doi. 10.1016/j.clml.2023.03.002
- By:
- Publication type:
- Article
P-140: Monoclonal proteinuria ≥200 mg/24h predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S111, doi. 10.1016/S2152-2650(21)02267-9
- By:
- Publication type:
- Article
OAB-037: Assessing the prognostic utility of the Mayo 2018 and IMWG 2020 smoldering multiple myeloma risk stratification scores applied post diagnosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S24, doi. 10.1016/S2152-2650(21)02111-X
- By:
- Publication type:
- Article
MM-429: Impact of Prolonged Lenalidomide Maintenance (≥3 years) and Outcomes in Patients with Multiple Myeloma Post-Autologous Stem Cell Transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S443, doi. 10.1016/S2152-2650(21)01986-8
- By:
- Publication type:
- Article
MM-431: A Comparison Between Daratumumab and Non-Daratumumab-Based Salvage Regimens Used at First Relapse Post-Lenalidomide Maintenance in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S444, doi. 10.1016/S2152-2650(21)01987-X
- By:
- Publication type:
- Article
MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S435, doi. 10.1016/S2152-2650(21)01970-4
- By:
- Publication type:
- Article
Poster: MM-431: A Comparison Between Daratumumab and Non-Daratumumab-Based Salvage Regimens Used at First Relapse Post-Lenalidomide Maintenance in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S256, doi. 10.1016/S2152-2650(21)01611-6
- By:
- Publication type:
- Article
Poster: MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S255, doi. 10.1016/S2152-2650(21)01605-0
- By:
- Publication type:
- Article
Poster: MM-429: Impact of Prolonged Lenalidomide Maintenance (≥3 years) and Outcomes in Patients with Multiple Myeloma Post-Autologous Stem Cell Transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S252, doi. 10.1016/S2152-2650(21)01580-9
- By:
- Publication type:
- Article
The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 7, p. 451, doi. 10.1016/j.clml.2021.02.001
- By:
- Publication type:
- Article
Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 355, doi. 10.1016/j.clml.2021.01.002
- By:
- Publication type:
- Article
Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The role of bone marrow biopsy in patients with plasma cell disorders; should all patients with a monoclonal protein be biopsied?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e333, doi. 10.1016/j.clml.2019.09.547
- By:
- Publication type:
- Article
Venetoclax For The Treatment of Translocation AL Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e332, doi. 10.1016/j.clml.2019.09.546
- By:
- Publication type:
- Article
Impact of Minimal Residual Negativity on Outcomes in Light Chain Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e331, doi. 10.1016/j.clml.2019.09.545
- By:
- Publication type:
- Article
Pilot study of Ixazomib, Lenalidomide, and Dexamethasone for Patients with POEMS Syndrome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e311, doi. 10.1016/j.clml.2019.09.512
- By:
- Publication type:
- Article